ArticleRheumatology (Oxford, England)2020

In vitro pharmacological effects of peficitinib on lymphocyte activation: a potential treatment for systemic sclerosis with JAK inhibitors.

Yukihiro Kitanaga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.